Rhythm

Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial

– A new, first-of-its-kind study known as TAP-CHF leverages expertise across Abbott’s cardiovascular portfolio to optimize treatment for patients suffering from both AFib and heart failure – The trial will utilize Abbott technology including cardiac ablation and sensors to monitor for both pulmonary artery pressure and abnormal heartbeats – Historically, […]

Hicuity Health Honored with MedTech Breakthrough Award for Second Consecutive Year

Company Earns “Best Hospital Technology Implementation” Recognition for System-Wide Expansion of Rhythm CI Remote Telemetry ST. LOUIS, May 6, 2021 /PRNewswire/ — Hicuity Health, the nation’s leading provider of high-acuity telemedicine services, announced that the company has been recognized by MedTech Breakthrough for the second consecutive year. The company earned recognition for the “Best Hospital […]

Eko Recognized for Artificial Intelligence Innovation in Healthcare with 2021 MedTech Breakthrough Awards

Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies OAKLAND, Calif., May 06, 2021 (GLOBE NEWSWIRE) — Eko, a cardiopulmonary digital health company, today announced that it has been selected as the winner of the “Best Use of Artificial Intelligence in Healthcare” award in the fifth annual MedTech […]

The Feasibility of 12-Lead Computational Analysis in Patients after COVID-19 Infection, using Vektor Medical’s vMap™, presented at Taiwan Heart Rhythm Society (THRS) 2021 Cutting-Edge Care for Heart Rhythm

vMap™ was presented as a technology that was able to provide arrhythmia insights for patients following COVID-19 infection, beyond those available from a standard 12-lead ECG CARLSBAD, Calif.–(BUSINESS WIRE)–Vektor Medical, Inc. announced that a single-center study conducted at the University of California San Diego reports that use of vMap™ (computational 12-lead ECG analysis) […]

Biobeat’s AI-Powered Remote Patient Monitoring Platform Receives A Full CE Mark

Remote Patient Monitoring Platform Provides Continuous Vital Sign Measurement and Patient Deterioration Identification Capabilities In Hospital and Home Settings PETAH TIKVA, Israel , May 4, 2021 /PRNewswire/ — Biobeat, a global leader in wearable remote patient monitoring solutions for the healthcare continuum, announced today that its full AI-powered wearable remote patient monitoring platform has received a […]

BioSig Sees Increased Case Volume from Expanding Base of Medical Centers Using Its Proprietary Signal Processing System

Westport, CT, May 04, 2021 (GLOBE NEWSWIRE) — The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021  44 physicians have conducted over 800 arrhythmia patient cases to date  Currently conducting patient cases in 9 medical centers […]

FineHeart Breaks New Ground With Successful Removal of the ICOMS FLOWMAKER® in a 90-day In-vivo Trial

Towards a new standard for device indication: Implantation for temporary or permanent use Easy removal with a beating heart without damage to the myocardium 30 days after implantation Normal heart functioning 60 days after explantation Completely sealed operation with dedicated implant fixation system Quick recovery and short hospital stay Autonomy […]

CorWave Presents an Unprecedented Chronic In Vivo Study at the 41st Annual Meeting of the International Society of Heart and Lung Transplantation

CLICHY, France–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung Transplantation (ISHLT). The company presented the first ever study demonstrating […]

AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients

FDA approval results in the only label of its kind for more than 3 million patients in the United States, significantly expanding AtriCure’s addressable market Superiority trial showed a 29% difference in effectiveness at 12 months and a 35% difference in effectiveness at 18 months for long-standing persistent Afib patients. Study […]

Aziyo Biologics Announces Initiation of De Novo CanGaroo Clinical Study

SILVER SPRING, Md., April 28, 2021 (GLOBE NEWSWIRE) — Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, announced today the initiation of a multi-center observational study to provide insight into the clinical […]